COMPOSITION FOR ALLEVIATING CORONAVIRUS INFECTION USING RALOXIFENE

• Main Authors: KIM, Pan Soo, LEE, Joo Yeon, KIM, Jin Hee, KIM, Kyung Chang, MIN, Ji Young, JEONG, Kwi Wan, CHANG, So Young, PARK, Sun Mi, KIM, Seung Taek, KIM, Young Eui
• Format: Patent
• Language: English; French; Korean
• Published: 23.09.2021
• Subjects: FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES

The present invention discloses a composition for alleviating coronavirus infection using raloxifene which has an activity of improving the viability of infected cells of coronaviruses SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43, SARS-CoV-2, or of inhibiting the propagation of the coronaviruses within cells. La présente invention concerne une composition pour soulager une infection à coronavirus à l'aide de raloxifène qui a une activité d'amélioration de la viabilité de cellules infectées par les coronavirus SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43, SARS-CoV-2, ou d'inhibition de la propagation des coronavirus dans les cellules. 본 발명은 코로나바이러스인 SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43, SARS-CoV-2의 감염세포 생존율을 향상시키거나 그 코로나바이러스 세포 내 증식을 억제하는 활성을 가진 랄록시펜을 코로나바이러스 감염증 개선용 조성물을 개시한다.